BONEFOS
BAYER INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is BONEFOS discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that BONEFOS 60MG has been permanently discontinued (last updated January 4, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is BONEFOS not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
OSTAC CAP 400MG
HOFFMANN-LA ROCHE LIMITED
CLASTEON
KNIGHT THERAPEUTICS INC.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
01984837
Strength
60MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Active Ingredient
CLODRONATE DISODIUM
Tier
Unrated
Last Updated
2019-01-04
Reason for Shortage
Business reasons
Other Products from BAYER INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
60MG · DIN 02155990
20MG · DIN 02237618
30MG · DIN 02155907
0.5MG · DIN 02412764
2MG · DIN 02412802
2.5MG · DIN 02412810
1MG · DIN 02412772
1.5MG · DIN 02412799
5MG · DIN 02243919
0.5MG · DIN 02247193
DIN 02309300
220MG · DIN 02436337